RHEUMATOID ARTHRITIS: CAUSES, SYMPTOMS, AND MODERN TREATMENT APPROACHES

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

RHEUMATOID ARTHRITIS: CAUSES, SYMPTOMS, AND MODERN

TREATMENT APPROACHES

Mavlonov Namoz Xalimovich

Associate Professor, Department of Internal Medicine in Family Medicine, Bukhara State

Medical Institute named after Abu Ali Ibn Sina, PhD

namoz_mavlonov@bsmi.uz

ORCID ID: 0000-0003-0348-9860

Abstract:

Rheumatoid arthritis (RA) is a chronic, autoimmune systemic inflammatory

disease that primarily affects the joints. It can also damage other organs such as the heart,

lungs, skin, and eyes. This article highlights the main clinical features, pathogenesis,

diagnostic methods, and treatment strategies for rheumatoid arthritis.

Keywords:

rheumatoid arthritis, autoimmune, joint inflammation, DMARDs, biologic

therapy.

Introduction

Rheumatoid arthritis is a chronic inflammatory disease of autoimmune origin that primarily

affects small joints symmetrically. The disease often begins between the ages of 30 and 50

and is 2 to 3 times more common in women than in men. Delayed diagnosis and inadequate

treatment may lead to disability, reduced quality of life, and potentially life-threatening

complications due to internal organ involvement.

1. Epidemiology

Globally, rheumatoid arthritis affects approximately 0.5–1% of the population. In countries

like Uzbekistan, Russia, and other Central Asian regions, official data may be limited, but

the prevalence is similar to global statistics. Women are affected 2–3 times more often than

men.

2. Pathogenesis

The development of rheumatoid arthritis is largely due to autoimmune mechanisms. The

immune system mistakenly produces autoantibodies (such as rheumatoid factor – RF and

anti-CCP antibodies) that attack the synovial tissue of the joints. This stimulates the release

of pro-inflammatory cytokines (e.g., TNF-α, IL-6), leading to joint swelling, synovial

membrane thickening, and eventual joint deformity and immobility.

3. Clinical Symptoms

Rheumatoid arthritis typically presents with the following symptoms:

Joint pain, especially morning stiffness lasting over an hour

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

Symmetrical joint swelling, often in fingers and toes

Fatigue, weight loss, loss of appetite

Low-grade fever

In severe cases, it may involve the heart (pericarditis), lungs (pleuritis), skin (rheumatoid

nodules), and eyes (scleritis)

4. Diagnostic Criteria

Diagnosis is based on the following:

Clinical signs: joint pain, prolonged morning stiffness, symmetrical joint involvement

Laboratory tests:

Rheumatoid factor (RF)

Anti-CCP antibodies

CRP and ESR (indicators of inflammation)

Imaging: X-ray, MRI, or ultrasound to detect joint damage

5. Treatment Approaches

The main goals of rheumatoid arthritis treatment are to reduce inflammation, suppress

disease activity, and prevent disability.

A. Medications:

NSAIDs – reduce inflammation and pain (e.g., ibuprofen, naproxen)

DMARDs (Disease-Modifying Anti-Rheumatic Drugs) – methotrexate, sulfasalazine,

leflunomide

Biologic agents – TNF-α inhibitors (e.g., etanercept, adalimumab), IL-6 inhibitors

Glucocorticoids – for short-term control of inflammation and swelling

B. Lifestyle Changes:

Balanced and healthy diet

Maintaining physical activity

Physical and occupational therapy

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

C. Surgery:

In severe cases of joint deformity, joint replacement surgery may be necessary

Conclusion

Rheumatoid arthritis is a long-term, serious condition that can be managed effectively with

early diagnosis and individualized treatment strategies. With proper medical care and

healthy lifestyle habits, many patients can live full and active lives despite the disease.

References (APA format)

1. Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Rheumatoid arthritis.

The Lancet,

388

(10055), 2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8

2. Aletaha, D., & Smolen, J. S. (2018). Diagnosis and management of rheumatoid arthritis:

A review.

JAMA, 320

(13), 1360–1372. https://doi.org/10.1001/jama.2018.13103

3. Singh, J. A., Saag, K. G., Bridges, S. L., et al. (2016). 2015 American College of

Rheumatology guideline for the treatment of rheumatoid arthritis.

Arthritis Care &

Research, 68

(1), 1–25. https://doi.org/10.1002/acr.22783

4. Firestein, G. S., & Kelley, W. N. (2020).

Kelley's Textbook of Rheumatology

(10th ed.).

Elsevier.

5. UpToDate. (2024). Overview of the management of rheumatoid arthritis in adults.

Retrieved from

https://www.uptodate.com